ZA200903429B - Genetic ablation of the PrP gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals - Google Patents

Genetic ablation of the PrP gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals

Info

Publication number
ZA200903429B
ZA200903429B ZA200903429A ZA200903429A ZA200903429B ZA 200903429 B ZA200903429 B ZA 200903429B ZA 200903429 A ZA200903429 A ZA 200903429A ZA 200903429 A ZA200903429 A ZA 200903429A ZA 200903429 B ZA200903429 B ZA 200903429B
Authority
ZA
South Africa
Prior art keywords
therapeuticals
serum
production
recombinant proteins
prp gene
Prior art date
Application number
ZA200903429A
Other languages
English (en)
Inventor
Carola Schroeder
Elisabeth Casademunt
Kim Bjoernstrup
Original Assignee
Octagene Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octagene Gmbh filed Critical Octagene Gmbh
Publication of ZA200903429B publication Critical patent/ZA200903429B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92Medium free of human- or animal-derived components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95Protein-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200903429A 2006-11-20 2009-05-19 Genetic ablation of the PrP gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals ZA200903429B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06124427 2006-11-20

Publications (1)

Publication Number Publication Date
ZA200903429B true ZA200903429B (en) 2010-04-28

Family

ID=37685785

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903429A ZA200903429B (en) 2006-11-20 2009-05-19 Genetic ablation of the PrP gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals

Country Status (12)

Country Link
EP (1) EP2084269A2 (ko)
KR (1) KR20090106474A (ko)
CN (1) CN101605891A (ko)
AU (1) AU2007324530A1 (ko)
BR (1) BRPI0718989A2 (ko)
CA (1) CA2670003A1 (ko)
IL (1) IL198770A0 (ko)
MX (1) MX2009005277A (ko)
NO (1) NO20091875L (ko)
RU (1) RU2009123458A (ko)
WO (1) WO2008061995A2 (ko)
ZA (1) ZA200903429B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2728900T3 (es) * 2010-05-12 2019-10-29 Janssen Biotech Inc Diferenciación de células madre embrionarias humanas
CN102277379B (zh) * 2011-08-18 2013-07-24 中国科学院遗传与发育生物学研究所 表达凝血因子viii的表达载体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
ATE288484T1 (de) * 1991-11-14 2005-02-15 Charles Weissmann Transgene nicht-menschliche tiere ohne prionprotein
NZ512309A (en) * 1998-12-22 2003-05-30 Univ California Prion-free therapeutic formulations produced from somatic cells with an artificially altered prion protein (PrP) gene
AU2001247773A1 (en) * 2000-03-24 2001-10-08 University Of Massachusetts, As Represented By Its Amherst Campus Prion-free transgenic ungulates
AU2002242854A1 (en) * 2001-03-21 2002-10-03 Geron Corporation Use of telomerase reverse transcriptase to create homozygous knockout animals

Also Published As

Publication number Publication date
WO2008061995A2 (en) 2008-05-29
CA2670003A1 (en) 2008-05-29
RU2009123458A (ru) 2010-12-27
EP2084269A2 (en) 2009-08-05
KR20090106474A (ko) 2009-10-09
IL198770A0 (en) 2011-08-01
WO2008061995A3 (en) 2008-07-10
AU2007324530A1 (en) 2008-05-29
MX2009005277A (es) 2009-05-28
CN101605891A (zh) 2009-12-16
NO20091875L (no) 2009-07-28
BRPI0718989A2 (pt) 2014-02-11

Similar Documents

Publication Publication Date Title
HK1251259B (zh) 用於重編程細胞的包含純化的經修飾的rna的rna製劑
EP2344672B8 (en) Genetic markers for optimizing treatment for schizophrenia
EP1827502A4 (en) PROCESS FOR THE TARGETED DELIVERY OF GENETIC MATERIAL TO THE LIVER
ZA200709897B (en) Improved methods controlling gene expression
HK1154031A1 (en) Optimized purification process of recombinant growth factor protein
PT3103874T (pt) Construção de novas variantes de dextrano-sacarase dsr-s através de engenharia genética
EP1981992A4 (en) PROMOTER CONSTRUCTION AND GENETIC CONTROL
EP1838837A4 (en) RECOMBINANT MICROORGANISMS FOR INCREASED PRODUCTION OF ORGANIC ACIDS
HK1130834A1 (en) Polynucleotide for production of recombinant protein by silkworm
IL206310A0 (en) Means for delivery of nucleic acids active for gene silencing using synthetic polymers
EP2126120A4 (en) Gene Expression Test Methods
TWI369401B (en) Serum-free culture medium for the production of recombinant gonadotropins
GB2442118B (en) Process for production of recombinant proteins as a soluble form
GB2446550B (en) Methods for production of recombinant alpha1-antitrypsin
IL199873A (en) Nucleic acid structure including ovalbumin promoter
ZA200903429B (en) Genetic ablation of the PrP gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals
EP2202313A4 (en) METHOD FOR PRODUCING RECOMBINANT DNA
EP2245164A4 (en) PLATFORM WITH SEVERAL PROMOTERS FOR PROTEIN PRODUCTION
EP2172550A4 (en) C-TERMINAL-A-AMIDATED RECOMBINANT ENZYME DERIVATIVE
EP2167665A4 (en) PROCESS FOR IMPROVING RECOMBINANT PROTEIN PRODUCTION
EP2064224A4 (en) TISSUE CULTURE SYSTEM FOR THE MANUFACTURE OF HEPATITIS C VIRUS
EP2084278A4 (en) GENE EXPRESSION IN PLANTS CONTROLLING NUCLEIC ACID PROMOTER SEQUENCES
ZA200604701B (en) Artificial bidirectional promoter for activation of gene expression
AU2007903867A0 (en) Genetic basis of improved milling yield
AU2007901242A0 (en) Genetic control of flour milling yield